Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3970)
All Articles published online
|
Dec 27, 2012 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O, Hassan M. Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World J Hepatol 2012; 4(12): 342-355 [PMID: 23355912 DOI: 10.4254/wjh.v4.i12.342] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v4/i12/342.htm |
| Number | Citing Articles |
| 1 |
Maria Lina Tornesello, Luigi Buonaguro, Francesco Izzo, Franco M. Buonaguro. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. Oncotarget 2016; 7(18): 25087 doi: 10.18632/oncotarget.7837
|
| 2 |
Javeria Khalid, Mohammad Umar, Tofeeq Ur-Rehman, Mashhood Ali, Gul Majid Khan. Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy. Infectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00300-z
|
| 3 |
O. V. Masalova, E. I. Lesnova, E. I. Samokhvalov, K. Yu. Permyakova, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cells. Molecular Biology 2017; 51(3): 453 doi: 10.1134/S0026893317030128
|
| 4 |
Gianni Testino, Paolo Borro. Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis. World Journal of Hepatology 2013; 5(10): 521-527 doi: 10.4254/wjh.v5.i10.521
|
| 5 |
Bin Han, Hadas Dvory-Sobol, Andrew Greenstein, Joseph F. McCarville, Magdeleine Hung, Xiaohong Liu, Michael D. Miller, Hongmei Mo. Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysate. Journal of Virological Methods 2015; 225: 76 doi: 10.1016/j.jviromet.2015.09.002
|
| 6 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 7 |
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis. Cancers 2024; 16(8): 1505 doi: 10.3390/cancers16081505
|
| 8 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 9 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 10 |
Maria C Sorbo, Luca Carioti, Maria C Bellocchi, FrancescoPaolo Antonucci, Daniele Sforza, Ilaria Lenci, Matteo Ciancio Manuelli, Daniele Armenia, Francesco De Leonardis, Martina Milana, Tommaso M Manzia, Mario Angelico, Giuseppe Tisone, Valeria Cento, Carlo F Perno, Francesca Ceccherini‐Silberstein. HCV resistance compartmentalization within tumoral and non‐tumoral liver in transplanted patients with hepatocellular carcinoma. Liver International 2019; 39(10): 1986 doi: 10.1111/liv.14168
|
| 11 |
Hélène Dubois‐Pot‐Schneider, Karim Fekir, Cédric Coulouarn, Denise Glaise, Caroline Aninat, Kathleen Jarnouen, Rémy Le Guével, Takashi Kubo, Seiichi Ishida, Fabrice Morel, Anne Corlu. Inflammatory cytokines promote the retrodifferentiation of tumor‐derived hepatocyte‐like cells to progenitor cells. Hepatology 2014; 60(6): 2077 doi: 10.1002/hep.27353
|
| 12 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
|
| 13 |
Trang H. Au, Christopher J. Destache, Renuga Vivekanandan. Hepatitis C therapy: Looking toward interferon-sparing regimens. Journal of the American Pharmacists Association 2015; 55(2): e72 doi: 10.1331/JAPhA.2015.15508
|
| 14 |
Jing Qin Wu, Monica Miranda Saksena, Vincent Soriano, Eugenia Vispo, Nitin K Saksena. Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs. Virology Journal 2015; 12(1) doi: 10.1186/s12985-014-0236-6
|
| 15 |
Ivan Schietroma, Giuseppe Corano Scheri, Claudia Pinacchio, Maura Statzu, Arnolfo Petruzziello, Vincenzo Vullo. Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals. The Open Virology Journal 2018; 12(1): 16 doi: 10.2174/1874357901812010016
|
| 16 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
|
| 17 |
Norica Branza-Nichita, Catalina Petrareanu, Catalin Lazar, Izabela Sokolowska, Costel C. Darie. Advancements of Mass Spectrometry in Biomedical Research. Advances in Experimental Medicine and Biology 2014; 806: 453 doi: 10.1007/978-3-319-06068-2_22
|
| 18 |
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
|
| 19 |
Aqsa Ikram, Bisma Rauff, Badr Alzahrani, Faryal Mehwish Awan, Ayesha Obaid, Anam Naz, Salik Javed Kakar, Hussnain Ahmed Janjua. Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19854-6
|
| 20 |
Ramareddy V. Guntaka, Mythili K. Padala. Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver Cancer. ISRN Virology 2014; 2014: 1 doi: 10.1155/2014/351407
|
| 21 |
Ikram Sghaier, Etienne Brochot, Besma Y. Loueslati, Wassim Y. Almawi. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis. Reviews in Medical Virology 2019; 29(2) doi: 10.1002/rmv.2033
|
| 22 |
Mariantonietta Pisaturo, Alessandra Di Fraia, Laura Occhiello, Carmine Minichini, Mario Starace, Valentina Iodice, Nunzia Farella, Maria Stanzione, Nicola Coppola. Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma. Infection and Drug Resistance 2021; : 5199 doi: 10.2147/IDR.S337647
|
| 23 |
Waqar Abd Al Qahar Al-Kubaisy, Kadhim Jawad Obaid, Nor Aini Mohd Noor, Nik Shamsidah Binti Nik Ibrahim, Ahmed Albu-Kareem Al-Azawi. Hepatitis C Virus Prevalence and Genotyping among Hepatocellular Carcinoma Patients in Baghdad. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7725 doi: 10.7314/APJCP.2014.15.18.7725
|
| 24 |
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, E. I. Samokhvalov, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cells. Molecular Biology 2016; 50(3): 422 doi: 10.1134/S0026893316020163
|
| 25 |
Maria Lina Tornesello, Luigi Buonaguro, Fabiana Tatangelo, Gerardo Botti, Francesco Izzo, Franco M. Buonaguro. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 2013; 102(2): 74 doi: 10.1016/j.ygeno.2013.04.001
|
| 26 |
Maximilian Bunz, Mona Eisele, Dan Hu, Michael Ritter, Julia Kammerloher, Sandra Lampl, Michael Schindler. CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1338606
|